Search

Your search keyword '"F. Bartholome"' showing total 4 results
Start Over Author "F. Bartholome"
4 results on '"F. Bartholome"'

1. P-15 Ambulatory eeg and sleep study in 194 treated depressed patients

Author

M. Casterman, J.M. Guerit, C. Witdoeckt, P. Troisfontaines, J.M. Hotermans, D. Massen, M. Joset, F. Bartholome, D. Raket, S. Bolyn, N. Lesnicki, P. Desfontaines, I. Hansen, A. Boxus, B. Pirotte, J.M. Kruger, F. Dewispelaere, and D. Debatisse

Subjects
Pharmacology, Psychiatry and Mental health, Neurology, Ambulatory EEG, business.industry, Anesthesia, Medicine, Pharmacology (medical), Neurology (clinical), Sleep study, business, Biological Psychiatry
Published
1996
Full Text
View/download PDF

2. P-14 Early P300 and late P300 in 415 treated patients suffering from a depressive syndrome

Author

S. Bolyn, J.M. Hotermans, A. Boxus, B. Pirotte, P. Troisfontaines, D. Rakett, F. Dewispelaere, M. Kruger, C. Witdoeckt, I. Hansen, D. Maassen, M. Joset, N. Lesnicki, D. Debatisse, F. Bartholome, M. Castermans, P. Desfontaines, and J.M. Guerit

Subjects
Pharmacology, Psychiatry and Mental health, Pediatrics, medicine.medical_specialty, Neurology, business.industry, medicine, Pharmacology (medical), Neurology (clinical), Depressive Syndrome, business, Biological Psychiatry
Published
1996
Full Text
View/download PDF

3. Comparative psychological aspects of two different types of chemotherapeutic administration (chronotherapy vs. traditional chemotherapy) on quality of life of cancer patients at advanced stage.

Author

Bertolini R, Focan C, Bartholome F, and Baro V

Subjects
Chronobiology Phenomena, Humans, Middle Aged, Neoplasms therapy, Psychiatric Status Rating Scales, Drug Therapy psychology, Neoplasms psychology
Abstract

In addition to qualitative information, specific quantitative psychiatrics tests (regarding anxiety and depression) and objective psychological tests specific to cancer populations were used to compare psychological variables in two groups of metastatic cancer patients treated with chemotherapy. The study also recorded 24 possible symptoms (somatic and psychic) allowing the self-evaluation of individual quality of life. The evaluation was performed at 7 different times (from before the beginning of treatment up to the 6th course). In comparison to traditional treatment, the results showed a better psychosocial adaptation for patients receiving chronoprogrammed administration of anticancer medication, with better social relations, less feelings of loss of independence, less anxiety, depression, and somatic discomfort.

Published
1995

4. A Belgian multicentre study of fluvoxamine in depressive outpatients.

Author

Brasseur R, Van Moffaert M, Mesotten F, Ansseau M, Uytdenhoef P, and Bartholome F

Subjects
Adult, Ambulatory Care, Antidepressive Agents administration & dosage, Depressive Disorder diagnosis, Female, Fluvoxamine, Humans, Male, Oximes administration & dosage, Psychiatric Status Rating Scales, Antidepressive Agents therapeutic use, Depressive Disorder drug therapy, Oximes therapeutic use
Abstract

Fluvoxamine, a new antidepressant that specifically inhibits serotonin reuptake, was studied in 272 outpatients in a six-week multicentre trial in Belgium. On the Hamilton Depression Scale, the mean score dropped from 25.2 to 8 after six weeks (p less than 0.00001). The Clinical Global Impression scores showed similar evolution. Fluvoxamine is a real antidepressant with a marked effect on mood. Its effective dosage is 100 mg to 200 mg/day. Its tolerance, notably at the cardiovascular level, is excellent.

Published
1985

Catalog

Books, media, physical & digital resources
See catalog results